A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
Conditions
Secondary Hyperparathyroidism
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Universitair Ziekenhuis Gent, Ghent, Belgium
Fakultni nemocnice v Motole, Prague, Czechia
Hospices Civils de Lyon Hopital Femme Mere Enfant, Bron, France
Hopital Armand Trousseau, Paris, France
Kindernierenzentrum Bonn, Bonn, Germany
Universitaetsklinikum Koeln, Cologne, Germany
Universitaetsklinikum Hamburg Eppendorf, Hamburg, Germany
Medizinische Hochschule Hannover, Hanover, Germany
Universitaetsklinikum Heidelberg, Zentrum fuer Kinder und Jugendmedizin, Heidelberg, Germany
General Children Hospital Panagioti and Aglaias Kyriakou, Athens, Greece
Ippokrateio General Hospital of Thessaloniki, Thessaloniki, Greece
Semmelweis Egyetem, Budapest, Hungary
Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar, Szeged, Hungary
Azienda Ospedaliera Universitaria Meyer, Florence, Italy
Childrens Hospital, Affiliate of Vilnius University Hospital Santaros Klinikos, Vilinus, Lithuania
Uniwersytecki Szpital Dzieciecy w Krakowie, Krakow, Poland
Unidade Local de Saude de Santo Antonio, EPE - Hospital de Santo Antonio, Porto, Portugal
Hospital Universitario Virgen del Rocio, Seville, Andalusia, Spain
Hospital Universitari Vall d Hebron, Barcelona, Catalonia, Spain
Royal Hospital for Sick Children, Glasgow, United Kingdom
Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
Great Ormond Street Hospital for Children, London, United Kingdom
University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
Study leads
MD
Study Director
Amgen